Insights to Heart Development and Cardiac Disease Models Using Pluripotent Stem Cell Derived 3D Organoids

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Dec 20

PMID 34926467

Citations 8

Authors

Jeremy Kah Sheng Pang

Beatrice Xuan Ho

Woon-Khiong Chan

Boon-Seng Soh

Affiliations

Soon will be listed here.

Abstract

Medical research in the recent years has achieved significant progress due to the increasing prominence of organoid technology. Various developed tissue organoids bridge the limitations of conventional 2D cell culture and animal models by recapitulating cellular complexity. Current 3D cardiac organoid cultures have shown their utility in modelling key developmental hallmarks of heart organogenesis, but the complexity of the organ demands a more versatile model that can investigate more fundamental parameters, such as structure, organization and compartmentalization of a functioning heart. This review will cover the prominence of cardiac organoids in recent research, unpack current 3D models of the developing heart and look into the prospect of developing physiologically appropriate cardiac organoids with translational applicability. In addition, we discuss some of the limitations of existing cardiac organoid models in modelling embryonic development of the heart and manifestation of cardiac diseases.

Citing Articles

Advances in cardiac organoid research: implications for cardiovascular disease treatment.

Huang Z, Jia K, Tan Y, Yu Y, Xiao W, Zhou X Cardiovasc Diabetol. 2025; 24(1):25.

PMID: 39827092 PMC: 11743075. DOI: 10.1186/s12933-025-02598-8.

Generative AI for Cell Type-Specific Fluorescence Image Generation of hPSC-derived Cardiac Organoid.

Kandula A, Phamornratanakun T, Gomez A, El-Mokahal M, Ma Z, Feng Y bioRxiv. 2024; .

PMID: 39149331 PMC: 11326121. DOI: 10.1101/2024.01.15.575724.

A miniaturized culture platform for control of the metabolic environment.

Orlowska M, Krycer J, Reid J, Mills R, Doran M, Hudson J Biomicrofluidics. 2024; 18(2):024101.

PMID: 38434908 PMC: 10908563. DOI: 10.1063/5.0169143.

Human induced pluripotent stem cell-derived planar neural organoids assembled on synthetic hydrogels.

Majumder J, Torr E, Aisenbrey E, Lebakken C, Favreau P, Richards W J Tissue Eng. 2024; 15:20417314241230633.

PMID: 38361535 PMC: 10868488. DOI: 10.1177/20417314241230633.

Recent Advances in Polycaprolactones for Anticancer Drug Delivery.

Bhadran A, Shah T, Babanyinah G, Polara H, Taslimy S, Biewer M Pharmaceutics. 2023; 15(7).

PMID: 37514163 PMC: 10385458. DOI: 10.3390/pharmaceutics15071977.

References

Campostrini G, Meraviglia V, Giacomelli E, van Helden R, Yiangou L, Davis R . Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells. Nat Protoc. 2021; 16(4):2213-2256. PMC: 7611409. DOI: 10.1038/s41596-021-00497-2. View

Burridge P, Anderson D, Priddle H, Munoz M, Chamberlain S, Allegrucci C . Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells. 2006; 25(4):929-38. DOI: 10.1634/stemcells.2006-0598. View

Mae S, Shono A, Shiota F, Yasuno T, Kajiwara M, Gotoda-Nishimura N . Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat Commun. 2013; 4:1367. PMC: 4447148. DOI: 10.1038/ncomms2378. View

Mannhardt I, Breckwoldt K, Letuffe-Breniere D, Schaaf S, Schulz H, Neuber C . Human Engineered Heart Tissue: Analysis of Contractile Force. Stem Cell Reports. 2016; 7(1):29-42. PMC: 4944531. DOI: 10.1016/j.stemcr.2016.04.011. View

Nawroth J, Scudder L, Halvorson R, Tresback J, Ferrier J, Sheehy S . Automated fabrication of photopatterned gelatin hydrogels for organ-on-chips applications. Biofabrication. 2018; 10(2):025004. PMC: 6221195. DOI: 10.1088/1758-5090/aa96de. View

Pesl M, Acimovic I, Pribyl J, Hezova R, Vilotic A, Fauconnier J . Forced aggregation and defined factors allow highly uniform-sized embryoid bodies and functional cardiomyocytes from human embryonic and induced pluripotent stem cells. Heart Vessels. 2013; 29(6):834-46. DOI: 10.1007/s00380-013-0436-9. View

Maltsev V, Rohwedel J, Hescheler J, Wobus A . Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev. 1993; 44(1):41-50. DOI: 10.1016/0925-4773(93)90015-p. View

Morizane R, Lam A, Freedman B, Kishi S, Valerius M, Bonventre J . Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol. 2015; 33(11):1193-200. PMC: 4747858. DOI: 10.1038/nbt.3392. View

Yang K, Breitbart A, de Lange W, Hofsteen P, Futakuchi-Tsuchida A, Xu J . Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells. JACC Basic Transl Sci. 2019; 3(6):728-740. PMC: 6314962. DOI: 10.1016/j.jacbts.2018.08.008. View

10.

Goldfracht I, Protze S, Shiti A, Setter N, Gruber A, Shaheen N . Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes. Nat Commun. 2020; 11(1):75. PMC: 6946709. DOI: 10.1038/s41467-019-13868-x. View

11.

Voges H, Mills R, Elliott D, Parton R, Porrello E, Hudson J . Development of a human cardiac organoid injury model reveals innate regenerative potential. Development. 2017; 144(6):1118-1127. DOI: 10.1242/dev.143966. View

12.

Miyamoto M, Nam L, Kannan S, Kwon C . Heart organoids and tissue models for modeling development and disease. Semin Cell Dev Biol. 2021; 118:119-128. PMC: 8513373. DOI: 10.1016/j.semcdb.2021.03.011. View

13.

Langhans S . Three-Dimensional Cell Culture Models in Drug Discovery and Drug Repositioning. Front Pharmacol. 2018; 9:6. PMC: 5787088. DOI: 10.3389/fphar.2018.00006. View

14.

Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T . Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013; 499(7459):481-4. DOI: 10.1038/nature12271. View

15.

Sun Y, Ding Q . Genome engineering of stem cell organoids for disease modeling. Protein Cell. 2017; 8(5):315-327. PMC: 5413597. DOI: 10.1007/s13238-016-0368-0. View

16.

Ma D, Wei H, Zhao Y, Lu J, Li G, Sahib N . Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. Int J Cardiol. 2013; 168(6):5277-86. DOI: 10.1016/j.ijcard.2013.08.015. View

17.

Lewis-Israeli Y, Wasserman A, Gabalski M, Volmert B, Ming Y, Ball K . Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease. Nat Commun. 2021; 12(1):5142. PMC: 8390749. DOI: 10.1038/s41467-021-25329-5. View

18.

Polonchuk L, Chabria M, Badi L, Hoflack J, Figtree G, Davies M . Cardiac spheroids as promising in vitro models to study the human heart microenvironment. Sci Rep. 2017; 7(1):7005. PMC: 5539326. DOI: 10.1038/s41598-017-06385-8. View

19.

Alpert M, Terry B, Kelly D . Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol. 1985; 55(6):783-6. DOI: 10.1016/0002-9149(85)90156-0. View

20.

Lee J, Sutani A, Kaneko R, Takeuchi J, Sasano T, Kohda T . In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix. Nat Commun. 2020; 11(1):4283. PMC: 7471119. DOI: 10.1038/s41467-020-18031-5. View